Search Results for: ELOB

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel ACSM5 acyl-CoA synthetase medium chain family member 5
  • Conjugation of salicylate with glycine
Novel CAPN1 calpain 1
  • Degradation of the extracellular matrix
  • Degradation of the extracellular matrix
  • Neutrophil degranulation
  • Formation of the cornified envelope
  • Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
  • Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
  • 4-[[(2S)-2-[[(2S)-3-Carboxy-2-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]butyl-(diaminomethylidene)azanium
  • N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1S)-3-fluoro-1-(4-hydroxybenzyl)-2-oxopropyl]-L-leucinamide
  • (2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE
Novel CCP110 centriolar coiled-coil protein 110
  • Regulation of PLK1 Activity at G2/M Transition
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • Ub-specific processing proteases
  • AURKA Activation by TPX2
Novel CDR2 cerebellar degeneration related protein 2
Novel DGAT2 diacylglycerol O-acyltransferase 2
  • Acyl chain remodeling of DAG and TAG
  • Triglyceride biosynthesis
  • Omega-3-carboxylic acids
  • Fish oil
Novel GPS2 G protein pathway suppressor 2
  • PPARA activates gene expression
  • HDACs deacetylate histones
  • Loss of MECP2 binding ability to the NCoR/SMRT complex
  • Regulation of MECP2 expression and activity
  • NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
  • HCMV Early Events
Novel HOXC10 homeobox C10
Novel SMG1 SMG1 nonsense mediated mRNA decay associated PI3K related kinase
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Novel STC2 stanniocalcin 2
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
Novel USP33 ubiquitin specific peptidase 33
  • Ub-specific processing proteases
  • Regulation of expression of SLITs and ROBOs
ASB11 ankyrin repeat and SOCS box containing 11
  • Neddylation
  • Antigen processing: Ubiquitination & Proteasome degradation
ASB2 ankyrin repeat and SOCS box containing 2
  • Neddylation
  • Antigen processing: Ubiquitination & Proteasome degradation
ASB8 ankyrin repeat and SOCS box containing 8
  • Neddylation
  • Antigen processing: Ubiquitination & Proteasome degradation
CEBPE CCAAT enhancer binding protein epsilon
  • Transcriptional regulation of granulopoiesis
  • Other phagocyte defects, including the following eight diseases: Chediak-Higashi syndrome; Griscelli syndrome, type 1 (GS1); Griscelli syndrome, type 2 (GS2); Griscelli syndrome, type 3 (GS3); beta-actin deficiency; Neutrophil-specific granule deficiency; Myeloperoxidase deficiency; Glucose 6-phosphate dehydrogenase deficiency; Shwachman syndrome
ELOA elongin A
  • Formation of RNA Pol II elongation complex
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • Pausing and recovery of Tat-mediated HIV elongation
  • Tat-mediated HIV elongation arrest and recovery
  • Tat-mediated elongation of the HIV-1 transcript
  • HIV elongation arrest and recovery
  • Pausing and recovery of HIV elongation
  • RNA Polymerase II Pre-transcription Events
  • TP53 Regulates Transcription of DNA Repair Genes
  • RNA Polymerase II Transcription Elongation
ELOA2 elongin A2
  • Formation of RNA Pol II elongation complex
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • Pausing and recovery of Tat-mediated HIV elongation
  • Tat-mediated HIV elongation arrest and recovery
  • Tat-mediated elongation of the HIV-1 transcript
  • HIV elongation arrest and recovery
  • Pausing and recovery of HIV elongation
  • RNA Polymerase II Pre-transcription Events
  • TP53 Regulates Transcription of DNA Repair Genes
  • RNA Polymerase II Transcription Elongation
ELOA3P elongin A3, pseudogene
  • Formation of RNA Pol II elongation complex
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • Pausing and recovery of Tat-mediated HIV elongation
  • Tat-mediated HIV elongation arrest and recovery
  • Tat-mediated elongation of the HIV-1 transcript
  • HIV elongation arrest and recovery
  • Pausing and recovery of HIV elongation
  • RNA Polymerase II Pre-transcription Events
  • TP53 Regulates Transcription of DNA Repair Genes
  • RNA Polymerase II Transcription Elongation
ELOC elongin C
  • Formation of RNA Pol II elongation complex
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • Pausing and recovery of Tat-mediated HIV elongation
  • Tat-mediated HIV elongation arrest and recovery
  • Tat-mediated elongation of the HIV-1 transcript
  • HIV elongation arrest and recovery
  • Pausing and recovery of HIV elongation
  • Vif-mediated degradation of APOBEC3G
  • RNA Polymerase II Pre-transcription Events
  • TP53 Regulates Transcription of DNA Repair Genes
  • RNA Polymerase II Transcription Elongation
  • Neddylation
  • Regulation of expression of SLITs and ROBOs
  • Antigen processing: Ubiquitination & Proteasome degradation
EPOR erythropoietin receptor
  • Signaling by Erythropoietin
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Erythropoietin activates Phospholipase C gamma (PLCG)
  • Erythropoietin activates STAT5
  • Erythropoietin activates RAS
  • Erythropoietin activates RAS
  • Darbepoetin alfa
  • Erythropoietin
  • Dibromotyrosine
  • Peginesatide
  • Methoxy polyethylene glycol-epoetin beta
  • Congenital polycythemia; Familial erythrocytosis (ECYT)
GHR growth hormone receptor
  • Prolactin receptor signaling
  • Growth hormone receptor signaling
  • Growth hormone receptor signaling
  • Somatotropin
  • Pegvisomant
  • Somatrem
  • Somapacitan
  • Pituitary Dwarfism (PD); Isolated growth hormone deficiency (IGHD); Short Stature and Pituitary Defects (SSPD); Insulin-like growth factor 1 deficiency (IGFD)

Page 1 out of 2 pages